BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1969777)

  • 1. Genetic counselling in Duchenne and Becker muscular dystrophy is problematic when carrier studies give controversial results.
    Kääriäinen H; Lindlöf M; Somer H; de la Chapelle A
    Clin Genet; 1990 Mar; 37(3):179-87. PubMed ID: 1969777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier detection and prenatal diagnosis in X linked muscular dystrophy using restriction fragment length polymorphisms.
    Lindlöf M; Kääriäinen H; Davies KE; de la Chapelle A
    J Med Genet; 1986 Dec; 23(6):560-72. PubMed ID: 2879928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis and carrier detection by DNA studies in a Duchenne muscular dystrophy family with no living affected male.
    Chen JD; Denton MJ; Serravalle S; Morgan G
    Aust Paediatr J; 1988 Dec; 24(6):351-3. PubMed ID: 2907402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular deletion analysis in Duchenne muscular dystrophy.
    Thomas NS; Ray PN; Worton RG; Harper PS
    J Med Genet; 1986 Dec; 23(6):509-15. PubMed ID: 2879923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of DNA probes to carrier detection and prenatal diagnosis of Duchenne (and Becker) muscular dystrophy.
    Mulley JC; Gedeon AK; Haan EA; Sheffield LJ; White SJ; Bates LJ; Robertson EF; Sutherland GR
    Aust Paediatr J; 1988; 24 Suppl 1():92-7. PubMed ID: 3202740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis of Duchenne and Becker muscular dystrophies: two years' experience in a comprehensive carrier screening and prenatal diagnostic laboratory.
    Laing NG; Mears ME; Chandler DC; Layton MG; Thomas HE; Johnsen RD; Goldblatt J; Kakulas BA
    Med J Aust; 1991 Jan; 154(1):14-8. PubMed ID: 1670611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
    Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
    Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier diagnosis of Duchenne muscular dystrophy using restriction fragment length polymorphisms.
    Hejtmancik JF; Harris SG; Tsao CC; Ward PA; Caskey CT
    Neurology; 1986 Dec; 36(12):1553-62. PubMed ID: 2878392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of DNA probes in detecting carriers of Duchenne muscular dystrophy: selected case studies.
    Prior TW; Blasco PA; Dove JL; Leshner RT; Gruemer HD
    Clin Chem; 1989 Apr; 35(4):679-83. PubMed ID: 2564818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA analysis of Duchenne and Becker muscular dystrophy using pERT87 genomic probes and dystrophin cDNA probes--establishing the optimum strategy for carrier diagnosis in the Japanese population.
    Ubagai T; Katayama S
    Jinrui Idengaku Zasshi; 1991 Sep; 36(3):211-27. PubMed ID: 1684391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure.
    Bakker E; Bonten EJ; De Lange LF; Veenema H; Majoor-Krakauer D; Hofker MH; Van Ommen GJ; Pearson PL
    J Med Genet; 1986 Dec; 23(6):573-80. PubMed ID: 2879929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients. Implications for genetic counseling.
    Alcántara MA; Villarreal MT; Del Castillo V; Gutiérrez G; Saldaña Y; Maulen I; Lee R; Macías M; Orozco L
    Clin Genet; 1999 May; 55(5):376-80. PubMed ID: 10422811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carrier detection and gene analysis in a Duchenne muscular dystrophy family].
    Lu FM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):231-3, 255. PubMed ID: 1979269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of 25 Chinese families with Duchenne/Becker muscular dystrophy.
    Ko TM; Chen CF; Chiu HC; Hsieh FJ; Lee TY
    J Formos Med Assoc; 1990 Oct; 89(10):850-6. PubMed ID: 1981771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragenic deletions in 164 boys with Duchenne muscular dystrophy (DMD) studied with dystrophin cDNA.
    Upadhyaya M; Smith RA; Thomas NS; Norman AM; Harper PS
    Clin Genet; 1990 Jun; 37(6):456-62. PubMed ID: 2200624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage studies in Duchenne and Becker muscular dystrophies.
    Walker A; Hart K; Cole C; Hodgson S; Johnson L; Dubowitz V; Bobrow M
    J Med Genet; 1986 Dec; 23(6):538-47. PubMed ID: 2879925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of linkage analysis to genetic counselling in families with Duchenne or Becker muscular dystrophy.
    Hodgson S; Walker A; Cole C; Hart K; Johnson L; Heckmatt J; Dubowitz V; Bobrow M
    J Med Genet; 1987 Mar; 24(3):152-9. PubMed ID: 3572997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial deletion in Becker type muscular dystrophy within the pXJ region.
    Liechti-Gallati S; Braga S; Hirsiger H; Moser H
    Hum Genet; 1987 Nov; 77(3):267-8. PubMed ID: 2890571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier assessment for mothers and sisters of isolated Duchenne dystrophy cases: the importance of serum enzyme determinations.
    Hyser CL; Doherty RA; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM
    Neurology; 1987 Sep; 37(9):1476-80. PubMed ID: 2888052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
    Moser H
    Hum Genet; 1984; 66(1):17-40. PubMed ID: 6365739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.